Pancrease MT

Pancrease MT is a pancreatic enzyme replacement therapy (PERT) delivered in delayed-release capsules containing enteric-coated microtablets. It is composed of pancrelipase, a mixture of three key digestive enzymes: lipase, protease, and amylase. This medication is indicated for the treatment of exocrine pancreatic insufficiency (EPI), a condition where the pancreas does not produce enough digestive enzymes, often associated with cystic fibrosis, chronic pancreatitis, or post-pancreatectomy conditions. The enteric coating protects the enzymes from gastric acid, allowing them to be released in the duodenum where they facilitate the breakdown of fats, proteins, and starches into absorbable nutrients.

Brand names

Pancrease MTPANCREASE® MTPancrease MT 4Pancrease MT 10Pancrease MT 16Pancrease MT 20Pancrease MT 25

Other names

Pancrelipase